{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:05:12Z","timestamp":1793275512247,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arcmed.2025.103335","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:20:41Z","timestamp":1762186841000},"page":"103335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6279-1527","authenticated-orcid":false,"given":"Mariana M.","family":"Ram\u00edrez-Mej\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-4291","authenticated-orcid":false,"given":"Guadalupe","family":"Ponciano-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-8048","authenticated-orcid":false,"given":"Nahum","family":"M\u00e9ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103335_bib0001","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13244-019-0716-8","article-title":"All about portal vein: a pictorial display to anatomy, variants and physiopathology","volume":"10","author":"Carneiro","year":"2019","journal-title":"Insights Imaging"},{"key":"10.1016\/j.arcmed.2025.103335_bib0003","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/livers1030014","article-title":"Targeting Gut\u2013Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension","volume":"1","author":"Kalo","year":"2021","journal-title":"Livers"},{"key":"10.1016\/j.arcmed.2025.103335_bib0004","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.arcmed.2025.103335_bib0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut\u2013liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1380713","article-title":"Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise","author":"Dmytriv","year":"2024","journal-title":"Front Physiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101859","article-title":"Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases","volume":"71","author":"Rodrigues","year":"2024","journal-title":"Semin Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0008","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11894-999-0023-5","article-title":"Intestinal permeability, leaky gut, and intestinal disorders","volume":"1","author":"Hollander","year":"1999","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0009","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.3748\/wjg.v25.i33.4814","article-title":"Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation","volume":"25","author":"Nicoletti","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0010","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.arcmed.2025.103335_bib0011","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1111\/liv.14696","article-title":"Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"40","author":"De Munck","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2025.103335_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1872-034X.2012.01054.x","article-title":"Intestinal permeability and complications in liver cirrhosis: A prospective cohort study","volume":"43","author":"Benjamin","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0013","first-page":"5153","article-title":"Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis","volume":"8","author":"Lin","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0014","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cimb46020078","article-title":"Gut\u2013Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury","volume":"46","author":"Tao","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0016","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.arcmed.2025.103335_bib0017","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jhep.2017.11.025","article-title":"Role of bile acids in the gut-liver axis","volume":"68","author":"Schneider","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0018","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103335_bib0019","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12182","article-title":"The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system","volume":"260","author":"Pelaseyed","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2025.103335_bib0021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/gmic.1.1.10470","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"1","author":"Hansson","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.arcmed.2025.103335_bib0022","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-513-8_14","article-title":"Ex vivo measurements of mucus secretion by colon explants","volume":"842","author":"Gustafsson","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0024","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s12276-023-00960-y","article-title":"Intestinal mucus components and secretion mechanisms: what we do and do not know","volume":"55","author":"Song","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.arcmed.2025.103335_bib0025","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.3390\/ijms16047493","article-title":"Impacts of gut bacteria on human health and diseases","volume":"16","author":"Zhang","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103335_bib0026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/rr25","article-title":"Epithelial antimicrobial peptides in host defense against infection","volume":"1","author":"Bals","year":"2000","journal-title":"Respir Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0027","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.3390\/ijms21239254","article-title":"Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells","volume":"21","author":"Pietrzak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103335_bib0028","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.micinf.2005.04.003","article-title":"The role of enterocytes in the intestinal barrier function and antigen uptake","volume":"7","author":"Snoeck","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.arcmed.2025.103335_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(91)90575-6","article-title":"Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease","volume":"100","author":"Mayer","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2025.103335_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5699(99)01575-3","article-title":"Antigen processing and presentation by intestinal epithelial cells - polarity and complexity","volume":"21","author":"Hershberg","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.arcmed.2025.103335_bib0031","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrmicro2546","article-title":"Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis","volume":"9","author":"Bevins","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0032","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","article-title":"Function and mechanisms of enteroendocrine cells and gut hormones in metabolism","volume":"15","author":"Gribble","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0033","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fimmu.2019.01499","article-title":"M Cells: Intelligent Engineering of Mucosal Immune Surveillance","volume":"10","author":"Dillon","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2645465","article-title":"Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals","author":"Lee","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/asj.13357","article-title":"Regulation of the intestinal barrier by nutrients: The role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Anim Sci J"},{"key":"10.1016\/j.arcmed.2025.103335_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1373208","article-title":"C\u00e2mara NOS. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life","volume":"5","author":"Takiishi","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.arcmed.2025.103335_bib0037","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/pharmrev.124.001202","article-title":"Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime","volume":"76","author":"Medina-Rodr\u00edguez","year":"2024","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.arcmed.2025.103335_bib0038","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41590-022-01284-1","article-title":"Inflammation triggers ILC3 patrolling of the intestinal barrier","volume":"23","author":"Jarade","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0039","doi-asserted-by":"crossref","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","article-title":"A cytokine network involving IL-36\u03b3, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2025.103335_bib0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.it.2017.11.003","article-title":"Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier","volume":"39","author":"Olivares-Villag\u00f3mez","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0041","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fimmu.2014.00488","article-title":"Cellular Plasticity of CD4+ T Cells in the Intestine","volume":"5","author":"Brucklacher-Waldert","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0042","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2009.08.011","article-title":"Regulatory T Cells Reinforce Intestinal Homeostasis","volume":"31","author":"Barnes","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.arcmed.2025.103335_bib0043","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13139","article-title":"B cell class switching in intestinal immunity in health and disease","volume":"95","author":"Fleming","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2025.103335_bib0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.arcmed.2025.103335_bib0046","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1462-2920.2007.01369.x","article-title":"Diversity of the human gastrointestinal tract microbiota revisited","volume":"9","author":"Rajili\u0107-Stojanovi\u0107","year":"2007","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0047","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/gut.2007.133603","article-title":"High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota","volume":"57","author":"Zoetendal","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103335_bib0048","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0049","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4254\/wjh.v13.i11.1512","article-title":"Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis","volume":"13","author":"Ma","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.908011","article-title":"The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease","volume":"13","author":"Ni","year":"2022","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2025.103335_bib0051","first-page":"S15","article-title":"The Role of the Gut Microbiota in Bile Acid Metabolism","volume":"16","author":"Ram\u00edrez-P\u00e9rez","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.arcmed.2025.103335_bib0053","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile Acid Physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0054","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"Suppl 2","key":"10.1016\/j.arcmed.2025.103335_bib0055","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2025.103335_bib0056","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0057","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile Acids as Hormones: The FXR-FGF15\/19 Pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.arcmed.2025.103335_bib0058","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.3390\/cells10113206","article-title":"The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity","volume":"10","author":"Anderson","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2025.103335_bib0059","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274124","article-title":"Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.arcmed.2025.103335_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13361","article-title":"The role of bile acid receptor TGR5 in regulating inflammatory signalling","volume":"99","author":"Ye","year":"2024","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0061","first-page":"227","article-title":"Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases","volume":"9","author":"Hern\u00e1ndez-Ceballos","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0062","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0063","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen","year":"2014","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0064","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/diseases7040058","article-title":"Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?","volume":"7","author":"Fukui","year":"2019","journal-title":"Diseases"},{"key":"10.1016\/j.arcmed.2025.103335_bib0065","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2025.103335_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2024.100471","article-title":"Firmicutes\/Bacteroidetes and Firmicutes\/Proteobacteria ratios are associated with worse prognosis in a cohort of Latin American patients with cirrhosis","volume":"79","author":"Mantovani","year":"2024","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.arcmed.2025.103335_bib0067","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103335_bib0068","doi-asserted-by":"crossref","DOI":"10.21037\/dmr-21-85","article-title":"Narrative review of gut microbiota and liver diseases: facts and fictions","volume":"5","author":"Valentin-Cortez","year":"2022","journal-title":"Dig Med Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0069","article-title":"Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease","volume":"9","author":"Ganesan","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103335_bib0070","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2025.103335_bib0071","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci Microbiota Food Health"},{"key":"10.1016\/j.arcmed.2025.103335_bib0072","doi-asserted-by":"crossref","first-page":"G589","DOI":"10.1152\/ajpgi.00245.2020","article-title":"Effects of dietary components on intestinal permeability in health and disease","volume":"319","author":"Khoshbin","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0073","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/advances\/nmz061","article-title":"Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review","volume":"11","author":"Rohr","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/j.arcmed.2025.103335_bib0074","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.arcmed.2025.103335_bib0075","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41575-024-00937-w","article-title":"Endogenous ethanol production in health and disease","volume":"21","author":"Meijnikman","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0076","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Research"},{"key":"10.1016\/j.arcmed.2025.103335_bib0077","doi-asserted-by":"crossref","first-page":"e1356","DOI":"10.1002\/iid3.1356","article-title":"Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis","volume":"12","author":"Chen","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.arcmed.2025.103335_bib0078","article-title":"Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes","volume":"46","author":"Rodrigues","year":"2023","journal-title":"Biomed J"},{"key":"10.1016\/j.arcmed.2025.103335_bib0079","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12964-024-01504-1","article-title":"The interaction of inflammasomes and gut microbiota: novel therapeutic insights","volume":"22","author":"Manshouri","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.arcmed.2025.103335_bib0080","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.csbj.2023.03.017","article-title":"Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis","volume":"21","author":"Yang","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2025.103335_bib0081","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101777","article-title":"From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Zhou","year":"2025","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0083","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13646","article-title":"Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"25","author":"Su","year":"2024","journal-title":"Obesity Reviews"},{"key":"10.1016\/j.arcmed.2025.103335_bib0084","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","article-title":"Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice","volume":"11","author":"Vel\u00e1zquez","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0086","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jnutbio.2015.05.011","article-title":"Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time","volume":"26","author":"Sellmann","year":"2015","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.arcmed.2025.103335_bib0087","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3390\/nu15071712","article-title":"Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus","volume":"15","author":"Tsai","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.arcmed.2025.103335_bib0088","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0183-1","article-title":"Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression","volume":"50","author":"Zhou","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.arcmed.2025.103335_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2025.103335_bib0091","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/microorganisms11082059","article-title":"The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Li","year":"2023","journal-title":"Microorganisms"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2025.103335_bib0092","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.5604\/01.3001.0010.5498","article-title":"Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances","volume":"16","author":"Cruz-Ram\u00f3n","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0093","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jgh.15027","article-title":"Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"35","author":"Chen","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0094","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2018-317155","article-title":"Identification of TMAO-producer phenotype and host\u2013diet\u2013gut dysbiosis by carnitine challenge test in human and germ-free mice","volume":"68","author":"Wu","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103335_bib0095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.arcmed.2025.103335_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113173","article-title":"Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance","volume":"142","author":"Nian","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0097","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.arcmed.2025.103335_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035008","article-title":"Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model","volume":"7","author":"Elamin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2025.103335_bib0099","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2353\/ajpath.2006.050617","article-title":"Impairment of the Intestinal Barrier by Ethanol Involves Enteric Microflora and Mast Cell Activation in Rodents","volume":"168","author":"Ferrier","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/19490976.2019.1595300","article-title":"Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice","volume":"11","author":"Bluemel","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.arcmed.2025.103335_bib0101","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12072-023-10518-9","article-title":"Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease","volume":"18","author":"Ganesan","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.arcmed.2025.103335_bib0102","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2025.103335_bib0103","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.hbpd.2023.06.008","article-title":"Contribution of gut microbiota to drug-induced liver injury","volume":"22","author":"Chu","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.arcmed.2025.103335_bib0104","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1432049","article-title":"Gut microbiota causally affects drug-induced liver injury via plasma metabolites: a Mendelian randomization study","volume":"15","author":"Fu","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0105","article-title":"Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0106","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2025.103335_bib0107","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0108","first-page":"15","article-title":"Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection","volume":"11","author":"Philips","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.gastro.2020.08.054","article-title":"Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis","volume":"160","author":"Sol\u00e9","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2025.103335_bib0110","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1038\/s41598-025-92618-0","article-title":"Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis","volume":"15","author":"Gulyaeva","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0111","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.3390\/ijms23168999","article-title":"The Link between Gut Microbiota and Hepatic Encephalopathy","volume":"23","author":"Won","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103335_bib0112","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/2050640618773564","article-title":"Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis","volume":"6","author":"Zhu","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.arcmed.2025.103335_bib0113","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12920-024-01939-y","article-title":"The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis","volume":"17","author":"Wu","year":"2024","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.arcmed.2025.103335_bib0114","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.999418","article-title":"Alterations of gut microbiota in cirrhotic patients with spontaneous bacterial peritonitis: A distinctive diagnostic feature","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41420-025-02413-z","article-title":"Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.arcmed.2025.103335_bib0116","first-page":"5","article-title":"The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer","volume":"6","author":"M\u00e9ndez-S\u00e1nchez","year":"2020","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.arcmed.2025.103335_bib0117","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2025.103335_bib0118","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00153-20","article-title":"Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma","volume":"5","author":"Lapidot","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.arcmed.2025.103335_bib0119","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","article-title":"Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma","volume":"68","author":"Ren","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.arcmed.2025.103335_bib0120","article-title":"Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials","volume":"11","author":"Yang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103335_bib0121","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12876-024-03356-y","article-title":"Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Gastroenterology"},{"key":"10.1016\/j.arcmed.2025.103335_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1358063","article-title":"Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis","volume":"14","author":"Xiong","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0123","first-page":"e0154","article-title":"Fecal microbiota transplant in liver diseases: Current evidence and future directions","volume":"23","author":"Karna","year":"2024","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.arcmed.2025.103335_bib0124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12967-025-06573-5","article-title":"Fecal microbiota transplantation from Helicobacter pylori carriers following bismuth quadruple therapy exacerbates alcohol-related liver disease in mice via LPS-induced activation of hepatic TLR4\/NF-\u03baB\/NLRP3 signaling","volume":"23","author":"Gao","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.arcmed.2025.103335_bib0127","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14728222.2025.2487465","article-title":"Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders","volume":"29","author":"Girisa","year":"2025","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.arcmed.2025.103335_bib0128","doi-asserted-by":"crossref","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103335_bib0129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2025.103335_bib0130","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","article-title":"Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis","volume":"79","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102530","volume":"49","author":"Kumar","year":"2025","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.arcmed.2025.103335_bib0132","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.gastha.2023.09.013","article-title":"Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases","volume":"3","author":"Almeqdadi","year":"2024","journal-title":"Gastro Hep Advances"},{"key":"10.1016\/j.arcmed.2025.103335_bib0133","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1741-7015-9-70","article-title":"The role of lifestyle changes in the management of chronic liver disease","volume":"9","author":"Nobili","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.arcmed.2025.103335_bib0134","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","article-title":"A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2025.103335_bib0135","doi-asserted-by":"crossref","first-page":"e01868","DOI":"10.1128\/spectrum.01868-23","article-title":"Healthy diet intervention reverses the progression of NASH through gut microbiota modulation","volume":"12","author":"Panyod","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.arcmed.2025.103335_bib0136","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clnu.2025.01.022","article-title":"Protein supplementation differentially alters gut microbiota and associated liver injury recovery in mouse model of alcohol-related liver disease","volume":"46","author":"Mittal","year":"2025","journal-title":"Clin Nutr"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:21:12Z","timestamp":1765617672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":136,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0188440925001559"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103335","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of the Liver-Gut Axis in Liver Disease: From Mechanisms to Therapeutic Targets","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103335"}}